📋 MIRA PHARMACEUTICALS, INC. (MIRA) - Legal Proceedings
Filing Date: 2026-07-31
Accepted: 2026-07-31 17:00:18
Event Type: Legal Proceedings
Event Details:
MIRA PHARMACEUTICALS, INC. (MIRA) Provides Business Update
MIRA PHARMACEUTICALS, INC. (MIRA) issued a business update covering recent developments.
anticipated in such forward-looking statements as a result of risks and uncertainties, including the risk that the Company may not regain compliance with the Minimum Bid Price Requirement, the risk that Nasdaq may not grant the Company relief from delisting if necessary, and the risk that the Company may not ultimately meet applicable Nasdaq requirements if any such relief is necessary, among other risks and uncertainties. A further description of the risks and uncertainties relating to the business of the Company is contained in the Company’s most recent annual report on Form 10-K and the Company’s other filings with the U.S. Securities and Exchange Commission (“SEC”), and in its future reports to be filed with the SEC and available at www.sec.gov. Forward-looking statements contained in this Current Report on Form 8-K are made as of this date, and the Company undertakes no duty to update such information whether as a result of new information, future events or otherwise, except as required under applicable law. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934
📋 MIRA PHARMACEUTICALS, INC. (MIRA) - Legal Proceedings
Filing Date: 2026-07-31
Accepted: 2026-07-31 17:00:18
Event Type: Legal Proceedings
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: